Fintel reports that on March 14, 2025, Wedbush upgraded their outlook for National CineMedia (NasdaqGS:NCMI) from Neutral to ...

In-theater advertising company National CineMedia Inc. is well-positioned to reap the benefits of cinema’s unique proposition ...

Wedbush said Friday it expects North American box office to rise at least 7% in 2025, with double-digit growth in the second ...

Equities research analysts at Wedbush upped their Q1 2025 earnings per share estimates for Beam Therapeutics in a research note issued on Monday, March 10th. Wedbush analyst D. Nierengarten now ...

Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Wedbush analyst Richard Anderson maintained a Sell rating on CareTrust REIT (CTRE – Research Report) today and set a price target of $26.00.

Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

Investment analysts at Wedbush boosted their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a research ...

Market fears over tariffs and growth have hit tech stocks, but Wedbush sees the dip as a buying opportunity for long-term investors ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Wedbush LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Wedbush, a Los Angeles-based financial services firm with global reach, and a legacy of innovation and client-focused investment solutions ...

Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...